Norman D. LaFrance

Entity
Individual
Business address
Molecular Insight Pharmceuticals, Inc., 160 Second Street, 02142 Cambridge, MA
Signature Ownership
/s/ Andrew Sims, attorney-in-fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Norman D. LaFrance has filed 14 SEC EDGAR filings since 4/26/2007

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 Feb 26, 2024 Feb 22, 2024 001-34375
4 Open Document Open Filing FORM 4 SUBMISSION Feb 17, 2023 Feb 15, 2023 001-34375
4/A Open Document Open Filing FORM 4/A SUBMISSION Mar 28, 2022 Nov 11, 2021 001-34375
4 Open Document Open Filing FORM 4 SUBMISSION Nov 24, 2021 Nov 11, 2021 001-34375
3 Open Document Open Filing FORM 3 SUBMISSION Nov 24, 2021 Nov 11, 2021 001-34375